Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: Time of flourescence recovery after photobleaching (FRAP) is an integrated measure of receptor function

Tomoshige Kino, Szu Heng Liou, Evangelia Charmandari, George P. Chrousos

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Natural mutations of the human glucocorticoid receptor (GR) isoform a cause the glucocorticoid resistance syndrome. Mutant receptors may have abnormal interactions with the ligand, target DNA sequences, and/or multiple intracellular proteins, as well as aberrant nucleocytoplasmic trafficking. Using fluorescence recovery after photobleaching (FRAP) analysis, all GR pathologic mutant receptors examined, as well as 2 synthetic GR mutants lacking the activation function (AF)-1 or the ligand-binding domain (and hence the AF-2), had defective transcriptional activity and dynamic motility defects inside the nucleus of living cells. In the presence of dexamethasone, these mutants displayed a curtailed 50% recovery time (t1/2) after photobleaching and, hence, significantly increased intranuclear motility and decreased "chromatin retention." The t1/2 values of the mutants correlated positively with their transcriptional activities and depended on the GR domain affected. GRβ, a natural splice variant of the GR gene, also demonstrated a shorter t1/2 than GRa. The motility responsiveness of the natural and artificial mutant receptors examined, and of GRβ, to the proteasomal inhibitor MG-132 also depended on the mutant domain. Thus, mutant glucocorticoid receptors possess dynamic motility defects in the nucleus, possibly caused by their inability to properly interact with all key partner nuclear molecules necessary for full activation of glucocorticoid-responsive genes.

Original languageEnglish
Pages (from-to)80-88
Number of pages9
JournalMolecular Medicine
Volume10
Issue number7-12
DOIs
Publication statusPublished - Jul 2004
Externally publishedYes

Fingerprint

Photobleaching
Glucocorticoid Receptors
Cell Nucleus
Artificial Receptors
Fluorescence Recovery After Photobleaching
Ligands
Dexamethasone
Glucocorticoids
Genes
Chromatin
Protein Isoforms
Mutation

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells : Time of flourescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. / Kino, Tomoshige; Liou, Szu Heng; Charmandari, Evangelia; Chrousos, George P.

In: Molecular Medicine, Vol. 10, No. 7-12, 07.2004, p. 80-88.

Research output: Contribution to journalArticle

@article{1b66d2b03f43469ea30e2013b40b8837,
title = "Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: Time of flourescence recovery after photobleaching (FRAP) is an integrated measure of receptor function",
abstract = "Natural mutations of the human glucocorticoid receptor (GR) isoform a cause the glucocorticoid resistance syndrome. Mutant receptors may have abnormal interactions with the ligand, target DNA sequences, and/or multiple intracellular proteins, as well as aberrant nucleocytoplasmic trafficking. Using fluorescence recovery after photobleaching (FRAP) analysis, all GR pathologic mutant receptors examined, as well as 2 synthetic GR mutants lacking the activation function (AF)-1 or the ligand-binding domain (and hence the AF-2), had defective transcriptional activity and dynamic motility defects inside the nucleus of living cells. In the presence of dexamethasone, these mutants displayed a curtailed 50{\%} recovery time (t1/2) after photobleaching and, hence, significantly increased intranuclear motility and decreased {"}chromatin retention.{"} The t1/2 values of the mutants correlated positively with their transcriptional activities and depended on the GR domain affected. GRβ, a natural splice variant of the GR gene, also demonstrated a shorter t1/2 than GRa. The motility responsiveness of the natural and artificial mutant receptors examined, and of GRβ, to the proteasomal inhibitor MG-132 also depended on the mutant domain. Thus, mutant glucocorticoid receptors possess dynamic motility defects in the nucleus, possibly caused by their inability to properly interact with all key partner nuclear molecules necessary for full activation of glucocorticoid-responsive genes.",
author = "Tomoshige Kino and Liou, {Szu Heng} and Evangelia Charmandari and Chrousos, {George P.}",
year = "2004",
month = "7",
doi = "10.2119/2005-00026.Kino",
language = "English",
volume = "10",
pages = "80--88",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "7-12",

}

TY - JOUR

T1 - Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells

T2 - Time of flourescence recovery after photobleaching (FRAP) is an integrated measure of receptor function

AU - Kino, Tomoshige

AU - Liou, Szu Heng

AU - Charmandari, Evangelia

AU - Chrousos, George P.

PY - 2004/7

Y1 - 2004/7

N2 - Natural mutations of the human glucocorticoid receptor (GR) isoform a cause the glucocorticoid resistance syndrome. Mutant receptors may have abnormal interactions with the ligand, target DNA sequences, and/or multiple intracellular proteins, as well as aberrant nucleocytoplasmic trafficking. Using fluorescence recovery after photobleaching (FRAP) analysis, all GR pathologic mutant receptors examined, as well as 2 synthetic GR mutants lacking the activation function (AF)-1 or the ligand-binding domain (and hence the AF-2), had defective transcriptional activity and dynamic motility defects inside the nucleus of living cells. In the presence of dexamethasone, these mutants displayed a curtailed 50% recovery time (t1/2) after photobleaching and, hence, significantly increased intranuclear motility and decreased "chromatin retention." The t1/2 values of the mutants correlated positively with their transcriptional activities and depended on the GR domain affected. GRβ, a natural splice variant of the GR gene, also demonstrated a shorter t1/2 than GRa. The motility responsiveness of the natural and artificial mutant receptors examined, and of GRβ, to the proteasomal inhibitor MG-132 also depended on the mutant domain. Thus, mutant glucocorticoid receptors possess dynamic motility defects in the nucleus, possibly caused by their inability to properly interact with all key partner nuclear molecules necessary for full activation of glucocorticoid-responsive genes.

AB - Natural mutations of the human glucocorticoid receptor (GR) isoform a cause the glucocorticoid resistance syndrome. Mutant receptors may have abnormal interactions with the ligand, target DNA sequences, and/or multiple intracellular proteins, as well as aberrant nucleocytoplasmic trafficking. Using fluorescence recovery after photobleaching (FRAP) analysis, all GR pathologic mutant receptors examined, as well as 2 synthetic GR mutants lacking the activation function (AF)-1 or the ligand-binding domain (and hence the AF-2), had defective transcriptional activity and dynamic motility defects inside the nucleus of living cells. In the presence of dexamethasone, these mutants displayed a curtailed 50% recovery time (t1/2) after photobleaching and, hence, significantly increased intranuclear motility and decreased "chromatin retention." The t1/2 values of the mutants correlated positively with their transcriptional activities and depended on the GR domain affected. GRβ, a natural splice variant of the GR gene, also demonstrated a shorter t1/2 than GRa. The motility responsiveness of the natural and artificial mutant receptors examined, and of GRβ, to the proteasomal inhibitor MG-132 also depended on the mutant domain. Thus, mutant glucocorticoid receptors possess dynamic motility defects in the nucleus, possibly caused by their inability to properly interact with all key partner nuclear molecules necessary for full activation of glucocorticoid-responsive genes.

UR - http://www.scopus.com/inward/record.url?scp=29244464325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244464325&partnerID=8YFLogxK

U2 - 10.2119/2005-00026.Kino

DO - 10.2119/2005-00026.Kino

M3 - Article

C2 - 16307173

AN - SCOPUS:29244464325

VL - 10

SP - 80

EP - 88

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 7-12

ER -